IRIS
CAGNACCI, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.273
SA - Sud America 19
AS - Asia 6
NA - Nord America 1
Totale 14.299
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.273
BR - Brasile 13
AR - Argentina 3
VN - Vietnam 3
EC - Ecuador 2
CN - Cina 1
ID - Indonesia 1
PY - Paraguay 1
SG - Singapore 1
US - Stati Uniti d'America 1
Totale 14.299
Salva come PNG Salva come JPEG
Città #
Genova 8.034
Genoa 4.047
Vado Ligure 1.268
Rapallo 834
Bordighera 84
Olzano 3
Aguaí 1
Ananindeua 1
Ashburn 1
Babakangarut 1
Boa Vista 1
Cabo Frio 1
Cà Mau 1
Feira de Santana 1
Gravataí 1
Guayaquil 1
Hanoi 1
Ho Chi Minh City 1
Jaguariúna 1
Joanópolis 1
Laferrere 1
Matinhos 1
Novara 1
Osasco 1
Quito 1
San Martín 1
San Pedro 1
Singapore 1
Sobral 1
São Paulo 1
Vargem Grande Paulista 1
Totale 14.295
Salva come PNG Salva come JPEG
Nome #
Asymptomatic SARS-CoV-2 infections in pregnant patients in an Italian city during the complete lockdown 141
Acupuncture or phy(F)itoestrogens vs. (E)strogen plus progestin on menopausal symptoms. A randomized study 133
Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study 125
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 124
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 122
Angle of Uterine Flexion and Adenomyosis 118
Age at menopause, extent of coronary artery disease and outcome among postmenopausal women with acute coronary syndromes 118
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 116
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study 115
Association between urinary incontinence and climacteric symptoms in postmenopausal women 113
Adenomyosis of the Extrapelvic Portion of the Round Ligament 113
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 109
Association between pelvic organ prolapse and climacteric symptoms in postmenopausal women 106
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 106
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 106
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 106
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group (.) 103
Bleeding profile in users of an etonogestrel sub-dermal implant: Effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population 102
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 101
Recommendations for contraception in women with diabetes. AMD-SIC position paper 101
Vasomotor symptoms and management of women undergoing treatment for breast cancer: literature review with focus on the therapeutic potential of cytoplasmic pollen extract 100
Dienogest mediates midkine suppression in endometriosis 99
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 97
Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study 97
Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives? 96
Hormone replacement therapy and prevention of chronic conditions 96
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 95
Integrated Clinical Pathways in vaginal and caesarean delivery: effect analysis 2016-2017, Italy 95
A comparison of the central effects of different progestins used in hormone replacement therapy 95
Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women 95
Seasonal trend of acute pelvic inflammatory disease 94
Oral contraceptives and insulin sensitivity 94
Intermenstrual pelvic pain, quality of life and mood 93
Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? 93
The relation of season of birth to severity of menopausal symptoms 93
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 92
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 91
The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study 91
Pharmacokinetic evaluation of desogestrel as a female contraceptive 91
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 90
Kava-Kava administration reduces anxiety in perimenopausal women 90
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status 89
Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO) 89
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study 88
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 87
Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis 87
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 86
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 86
Medical and patient attitude towards vaginal atrophy: the AGATA study 86
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 85
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 85
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study 84
Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels 84
Relationship between urinary estrogen levels before conception and sex ratio at birth in a primate, the gray mouse lemur 84
Folate administration decreases oxidative status and blood pressure in postmenopausal women 84
Management of vaginal atrophy: a real mess. Results from the AGATA study 83
Chronic pelvic pain improvement: impact on quality of life and mood 83
European society of contraception statement on contraception in obese women 82
Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: a case-control study 82
Contraception in cancer survivors–an expert review Part II. Skin, gastrointestinal, haematological and endocrine cancers 82
Role of close endocervical margin in treatment failure after cervical excision for cervical intraepithelial neoplasia: A retrospective study 82
Influences of maternal weight on the secondary sex ratio of human offspring 81
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 81
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 81
Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women 80
Seasonal onset of the menopause 80
Vaginal atrophy across the menopausal age: results from the ANGEL study 80
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 80
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 80
The Controversial History of Hormone Replacement Therapy 80
Anthropometric Features and Third-Fourth Degree Perineal Tears 79
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 79
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause 79
Age-related difference in the rate of coronavirus disease 2019 mortality in women versus men 79
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function 78
Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation 78
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 78
Massive Hemoperitoneum from Uterine Leiomyoma Associated with Diffuse Myometrial Venous Congestion 78
Small fetal thymus and adverse obstetrical outcome: a systematic review and a meta-analysis 78
Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis 78
Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study 77
Role of melatonin in circadian rhythm at menopause 77
Maternal and perinatal outcomes in high compared to low risk pregnancies complicated by severe acute respiratory syndrome coronavirus 2 infection (phase 2): the World Association of Perinatal Medicine working group on coronavirus disease 2019 77
Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivors 76
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 76
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 76
Prolonged melatonin administration decreases nocturnal blood pressure in women 76
History of vasomotor symptoms, extent of coronary artery disease, and clinical outcomes after acute coronary syndrome in postmenopausal women 76
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 76
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 76
Hormonal contraception: venous and arterial disease 76
Prevalence of menstrual pain in young women: what is dysmenorrhea 76
Season of birth influences the timing of menopause 75
The male disadvantage and the seasonal rhythm of sex ratio at the time of conception 75
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 75
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 75
Histological evaluation of the prevalence of adenomyosis, myomas and of their concomitance 75
Effects of low- or high-dose hormone therapy on fasting and post-methionine homocysteine levels in postmenopausal women 75
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures 75
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women 74
Totale 8.974
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.736
article - articoli 65.749
book - libri 0
conference - conferenze 356
curatela - curatele 0
other - altro 355
patent - brevetti 0
selected - selezionate 0
volume - volumi 276
Totale 133.472
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.224 0 0 0 171 64 97 101 206 114 248 124 99
2021/20221.751 91 38 46 163 33 221 27 429 242 113 104 244
2022/20231.269 213 64 5 83 126 134 14 79 216 12 289 34
2023/2024823 44 120 26 92 68 35 35 92 29 32 66 184
2024/20252.969 67 319 71 92 521 327 316 285 178 208 188 397
2025/20261.364 606 141 329 288 0 0 0 0 0 0 0 0
Totale 14.823